654Indexed trials
mesh condition
Parkinson Disease
Intelligence
Parkinson Disease intelligence: 654 indexed trials, 139 recruiting studies, 409 sponsors across 61 countries.
139Recruiting
409Sponsors
61Countries
Leading sponsors
Washington University School of Medicine83 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)81 recruiting
AbbVie71 recruiting
InSightec74 recruiting
Bial - Portela C S.A.70 recruiting
Radboud University Medical Center61 recruiting
University Hospital, Toulouse61 recruiting
UCB Pharma60 recruiting
Boehringer Ingelheim60 recruiting
University of Michigan63 recruiting
Stanford University52 recruiting
China Medical University Hospital51 recruiting
Geographic activity
United States266trials
France61trials
Germany50trials
Italy48trials
Spain41trials
Canada41trials
United Kingdom39trials
China32trials
Netherlands23trials
Turkey (Türkiye)22trials
Brazil22trials
Taiwan20trials
Leading interventions
Deep Brain Stimulation6trials
Rotigotine5trials
tDCS5trials
Transcranial direct current stimulation5trials
Pramipexole4trials
Donepezil3trials
Sham Surgery3trials
Physiotherapy3trials
Exercise3trials
Nicotinamide Riboside3trials
ABBV-9513trials
LY030033trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.